Learn More
Invitrogen™ Human MRI1 (aa 272-361) Control Fragment Recombinant Protein
Description
Highest antigen sequence indentity to the following orthologs: Mouse (82%), Rat (82%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-60100 (PA5-60100. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Specifications
Specifications
| Accession Number | Q9BV20 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 84245 |
| Name | Human MRI1 (aa 272-361) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 2410018C20Rik; CH73-131E21.1; HAMAP-Rule:MF_03119}; M1Pi; M1Pi {ECO:0000255; mediator of RhoA-dependent invasion; Methylthioribose-1-phosphate isomerase; methylthioribose-1-phosphate isomerase {ECO:0000255; methylthioribose-1-phosphate isomerase 1; methylthioribose-1-phosphate isomerase homolog; methylthioribose-1-phosphate isomerase homolog (S. cerevisiae); MGC3207; MRDI; Mri1; MTNA; MTR-1-P isomerase; MTR-1-P isomerase {ECO:0000255; RGD1307789; similar to CG11334-PB, isoform B; S-methyl-5-thioribose-1-phosphate isomerase; S-methyl-5-thioribose-1-phosphate isomerase {ECO:0000255; S-methyl-5-thioribose-1-phosphate isomerase 1; translation initiation factor eIF-2 B subunit alpha/beta/delta-like protein; translation initiation factor eIF-2 B subunit alpha/beta/delta-like protein {ECO:0000255; UNQ6390/PRO21135; Ypr118w; zgc:172216 |
| Common Name | MRI1 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.